Pre-transplant course and risk of kidney transplant failure in IgA nephropathy patients

Clinical Transplantation

Volumn 25, Issue 3, 2011, Pages

  Bjørneklett, Rune ^a,b   Vikse, Bjørn Egil ^a,b   Smerud, Hilde Kloster ^c   Bostad, Leif ^a,d   Leivestad, Torbjørn ^e   Hartmann, Anders ^e   Iversen, Bjarne M ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c Smerud Medical Research International AS   (Norway)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

ESRD; Graft loss; IgA nephropathy; Kidney transplantation; Living donor; Recurrence of IgA nephropathy

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; STEROID;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, IGA; GRAFT REJECTION; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SURVIVAL RATE;

EID: 79958745842     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2011.01424.x     Document Type: Article

References (27)

1. D'Amico G. The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987: 64: 709.
2. Julian BA, Waldo FB, Rifai A, Mestecky J. IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States? Am J Med 1988: 84: 129.
3. Levy M, Berger J. Worldwide perspective of IgA nephropathy. Am J Kidney Dis 1988: 12: 340.
4. D'Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 2000: 36: 227.
5. Geddes CC, Rauta V, Gronhagen-Riska C et al. A tricontinental view of IgA nephropathy. Nephrol Dial Transplant 2003: 18: 1541.
6. Simmons RG, Abress L. Quality-of-life issues for end-stage renal disease patients. Am J Kidney Dis 1990: 15: 201.
7. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999: 341: 1725.
8. Eggers P. Comparison of treatment costs between dialysis and transplantation. Semin Nephrol 1992: 12: 284.
9. Cecka JM. The UNOS renal transplant registry. Clin Transpl 2001: 1: 1.
10. Andresdottir MB, Hoitsma AJ, Assmann KJ, Wetzels JF. Favorable outcome of renal transplantation in patients with IgA nephropathy. Clin Nephrol 2001: 56: 279.
11. Prommool S, Jhangri GS, Cockfield SM, Halloran PF. Time dependency of factors affecting renal allograft survival. J Am Soc Nephrol 2000: 11: 565.
12. Berger J. Recurrence of IgA nephropathy in renal allografts. Am J Kidney Dis 1988: 12: 371.
13. Briganti EM, Russ GR, McNeil JJ, Atkins RC, Chadban SJ. Risk of renal allograft loss from recurrent glomerulonephritis. N Engl J Med 2002: 347: 103.
14. Freese P, Svalander C, Norden G, Nyberg G. Clinical risk factors for recurrence of IgA nephropathy. Clin Transplant 1999: 13: 313.
15. Frohnert PP, Donadio JV Jr, Velosa JA, Holley KE, Sterioff S. The fate of renal transplants in patients with IgA nephropathy. Clin Transplant 1997: 11: 127.
16. Kessler M, Hiesse C, Hestin D, Mayeux D, Boubenider K, Charpentier B. Recurrence of immunoglobulin A nephropathy after renal transplantation in the cyclosporine era. Am J Kidney Dis 1996: 28: 99.
17. Ohmacht C, Kliem V, Burg M et al. Recurrent immunoglobulin A nephropathy after renal transplantation: a significant contributor to graft loss. Transplantation 1997: 64: 1493.
18. Wang AY, Lai FM, Yu AW et al. Recurrent IgA nephropathy in renal transplant allografts. Am J Kidney Dis 2001: 38: 588.
19. Port FK, Dykstra DM, Merion RM, Wolfe RA. Trends and results for organ donation and transplantation in the United States, 2004. Am J Transplant 2005: 5: 843.
20. Bumgardner GL, Amend WC, Ascher NL, Vincenti FG. Single-center long-term results of renal transplantation for IgA nephropathy. Transplantation 1998: 65: 1053.
21. Choy BY, Kar N. Recurrent IgA nephropathy in transplant. In: Lai KN ed. Recent Advances in IgA Nephropathy, 1st edn. Hong Kong: World Scientific, 2009: 149.
22. Kowalewska J, Yuan S, Sustento-Reodica N et al. IgA nephropathy with crescents in kidney transplant recipients. Am J Kidney Dis 2005: 45: 167.
23. Mousson C, Charon-Barra C, Funes de la Vega M et al. Recurrence of IgA nephropathy with crescents in kidney transplants. Transplant Proc 2007: 39: 2595.
24. Tang Z, Ji SM, Chen DR et al. Recurrent or de novo IgA nephropathy with crescent formation after renal transplantation. Ren Fail 2008: 30: 611.
25. Churg JBJ, Glassock R. IgA Nephropathy. In: Churg JBJ, Glassock R ed. Renal Disease-Classification and Atlas of Glomerular Diseases, 2nd edn. New York, Tokyo: IGAKU-SHOIN, 1995: 181.
26. Sakai H, Abe K, Kobayashi Y et al. Clinical guidelines of IgA nephropathy. Nippon Jinzo Gakkai Shi 1995: 37: 417.
27. Goto M, Wakai K, Kawamura T, Ando M, Endoh M, Tomino Y. A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study. Nephrol Dial Transplant 2009: 24: 3068.